91057-32-8

Usage

Synthesis Reference(s)

The Journal of Organic Chemistry, 16, p. 920, 1951 DOI: 10.1021/jo01146a015

Upstream product

• 93257-33-1 3-methoxycarbonyl-3,5,5-trimethylcyclohexanone 
• 7027-11-4 isophoronenitrile 
• 78-59-1 3,5,5-Trimethylcyclohex-2-en-1-one 
• 90925-97-6 3,7-Dioxo-1,5,5-trimethyl-norbornan 
• 124-38-9 carbon dioxide 

Downstream Products

• 1321999-44-3 C₁₆H₂₀ClNO₂ 
• 1321999-43-2 C₁₆H₂₁NO₂ 
• 93257-33-1 3-methoxycarbonyl-3,5,5-trimethylcyclohexanone 

Relevant academic research and scientific papers

COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA

A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1 to R4 and Ar are as defined in description and in claims, can be used as a medicament.

COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA

A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1 to R4 and Ar are as defined in description and in claims, can be used as a medicament.

COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA

A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1 to R4 and Ar are as defined in description and in claims, can be used as a medicament.

Electrocarboxylation de composes carbonyles aliphatiques, aromatiques et vinyliques: interet de l'utilisation d'une anode consommable en magnesium

In the presence of carbon dioxide in DMF, the electroreduction of carbonyl compounds or α,β-ketoalkenes at high concentration yields respectively α-hydroxyacids and β-ketoacids.The use of a sacrificial magnesium anode allows constant current electrolyses in a diaphragmless cell.